Mark T. Brown

发表

Core outcome domains and measures for pediatric acute and chronic/recurrent pain clinical trials: PedIMMPACT recommendations.

Steven Weisman, Christopher Eccleston, Thomas Rhodes, 2008, The journal of pain : official journal of the American Pain Society.

Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.

T. Schnitzer, I. Davignon, G. Pixton, 2019, JAMA.

Efficacy and safety of tanezumab in the treatment of pain from bone metastases

Mark T. Brown, C. West, K. Verburg, 2015, Pain.

Multiple-day Efficacy of Parecoxib Sodium Treatment in Postoperative Bunionectomy Pain

P. Desjardins, J. Apfelbaum, Mark T. Brown, 2008, The Clinical journal of pain.

Valdecoxib for Treatment of a Single, Acute, Moderate to Severe Migraine Headache

D. Kudrow, G. Ruoff, Mark T. Brown, 2005, Headache.

Efficacy and safety of tanezumab versus naproxen in the treatment of chronic low back pain

A. Kivitz, J. Gimbel, M. A. Nemeth, 2013, PAIN®.

Long-term safety and effectiveness of tanezumab as treatment for chronic low back pain

A. Kivitz, J. Gimbel, M. A. Nemeth, 2014, PAIN®.

Neurological safety of subcutaneous tanezumab versus NSAID in patients with osteoarthritis

P. Sandroni, G. Pixton, L. Viktrup, 2022, Journal of the Neurological Sciences.

Analgesic efficacy of valdecoxib for acute postoperative pain after bunionectomy.

H. Hillstrom, K. Mahan, D. Riff, 2006, Journal of the American Podiatric Medical Association.

Development of pain therapies targeting nerve growth factor signal transduction and the strategies used to resolve safety issues.

Mark T. Brown, C. West, P. Bélanger, 2018, The Journal of toxicological sciences.

Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period

A. Guermazi, F. Berenbaum, K. Miki, 2020, Annals of the Rheumatic Diseases.

Tanezumab for chronic low back pain: a long-term, randomized, celecoxib-controlled Japanese Phase III safety study.

S. Konno, J. Markman, L. Viktrup, 2021, Pain management.

Long‐Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial

T. Schnitzer, M. Hochberg, J. Carrino, 2021, Arthritis & rheumatology.

Acute leukemia following treatment of malignant glioma

J. Gockerman, J. Perry, Mark T. Brown, 1998, Journal of Neuro-Oncology.

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.

Andreas Hoeft, A. Hoeft, N. Nussmeier, 2005, The New England journal of medicine.

The selective norepinephrine reuptake inhibitor antidepressant reboxetine: pharmacological and clinical profile.

E. Wong, M. Hajós, J. Fleishaker, 2006, CNS drug reviews.

Lack of sexual dysfunction with the selective noradrenaline reuptake inhibitor reboxetine during treatment for major depressive disorder

J. Zajecka, A. Clayton, Mark T. Brown, 2003, International clinical psychopharmacology.

Efficacy and safety of tanezumab in the treatment of chronic low back pain

C. Birbara, D. Borenstein, M. A. Nemeth, 2011, PAIN®.

Safety and Efficacy of the Cyclooxygenase-2 Inhibitors Parecoxib and Valdecoxib after Noncardiac Surgery

N. Nussmeier, G. Joshi, N. Singla, 2006, Anesthesiology.

Parecoxib sodium administered over several days reduces pain after gynecologic surgery via laparotomy

J. Kotarski, Mark T. Brown, K. Verburg, 2007 .

A Multiple-Day Regimen of Parecoxib Sodium 20 mg Twice Daily Provides Pain Relief After Total Hip Arthroplasty

A. Halder, E. Viscusi, J. Gimbel, 2008, Anesthesia and analgesia.

Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial.

D. Borenstein, N. Nangia, Mark T. Brown, 2004, Clinical therapeutics.

Parecoxib sodium administered over several days reduces pain after gynecologic surgery via laparotomy.

J. Kotarski, Mark T. Brown, K. Verburg, 2008, Journal of clinical anesthesia.

Microvascular reconstruction of cranial base defects: An evaluation of complication and survival rates to justify the use of this repair.

A. Chalian, J. Newman, B. O'Malley, 2006, Archives of Otolaryngology - Head and Neck Surgery.

Subcutaneous tanezumab for osteoarthritis: Is the early improvement in pain and function meaningful and sustained?

F. Berenbaum, K. Miki, F. Blanco, 2021, European journal of pain.

Exploring the role of tanezumab as a novel treatment for the relief of neuropathic pain.

P. Dyck, D. Herrmann, Mark T. Brown, 2015, Pain medicine.

A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee

E. Spierings, Mark T. Brown, C. West, 2013, PAIN®.

Tanezumab for the treatment of pain from osteoarthritis of the knee.

T. Schnitzer, N. Lane, C. Birbara, 2010, The New England journal of medicine.

Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip

T. Schnitzer, Mark T. Brown, C. West, 2019, Journal of pain research.

Atlas of Regional and Free Flaps for Head and Neck Reconstruction

Mark T. Brown, 1996 .

Primary central nervous system lymphoma with systemic metastasis: Case report and review

J. Gockerman, Mark T. Brown, Roger E. Mc Clendon, 2005, Journal of Neuro-Oncology.

Assessment of plasma tissue factor activity in patients presenting with coronary artery disease: limitations of a commercial assay

R. Riddell, M. Konstam, K. Horgan, 2009 .

Efficacy and safety of tanezumab monotherapy or combined with non-steroidal anti-inflammatory drugs in the treatment of knee or hip osteoarthritis pain.

T. Schnitzer, H. Greenberg, E. Ekman, 2015, Annals of the rheumatic diseases.

Nerve safety of tanezumab, a nerve growth factor inhibitor for pain treatment

P. Dyck, D. Herrmann, Mark T. Brown, 2014, Journal of the Neurological Sciences.

Response to letter by Ackermann

C. Birbara, D. Borenstein, Mark T. Brown, 2012, PAIN®.

Tanezumab reduces osteoarthritic hip pain: results of a randomized, double-blind, placebo-controlled phase III trial.

I. Davignon, Mark T. Brown, C. West, 2013, Arthritis and rheumatism.

A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.

A. Kivitz, Mark T. Brown, K. Verburg, 2006, Clinical therapeutics.

Development of an imaging mitigation strategy for patient enrolment in the tanezumab nerve growth factor inhibitor (NGF-ab) program with a focus on eligibility assessment.

A. Guermazi, F. Roemer, M. Crema, 2017, Seminars in arthritis and rheumatism.

Tanezumab reduces osteoarthritic knee pain: results of a randomized, double-blind, placebo-controlled phase III trial.

I. Davignon, Mark T. Brown, C. West, 2012, The journal of pain : official journal of the American Pain Society.

Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial

I. Davignon, E. Feist, Mark T. Brown, 2013, Annals of the rheumatic diseases.

Efficacy and Safety of Intravenous Tanezumab for the Symptomatic Treatment of Osteoarthritis: 2 Randomized Controlled Trials versus Naproxen

E. Ekman, J. Gimbel, Mark T. Brown, 2014, The Journal of Rheumatology.

Complications of the Cox-II inhibitors parecoxib and valdecoxib after cardiac surgery

N. Nussmeier, A. Whelton, Mark T. Brown, 2005 .

Tanezumab Does Not Cause Sympathetic Nervous System Dysfunction in Clinical Osteoarthritis Studies (P3.303)

M. Koltzenburg, Mark T. Brown, C. West, 2015 .

NEUROPATHIC PAIN SECTION Original Research Article Exploring the Role of Tanezumab as a Novel Treatment for the Relief of Neuropathic Pain

P. Dyck, D. Herrmann, Mark T. Brown, 2016 .

Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study.

T. Schnitzer, I. Davignon, G. Pixton, 2020, Seminars in arthritis and rheumatism.

First-in-human randomized clinical trials of the safety and efficacy of tanezumab for treatment of chronic knee osteoarthritis pain or acute bunionectomy pain

F. Hefti, P. Walicke, Mark T. Brown, 2018, Pain reports.

Safety and efficacy of subcutaneous tanezumab in patients with knee or hip osteoarthritis

C. Birbara, E. Dabezies, R. Fountaine, 2018, Journal of pain research.

randomised clinical trial parallel-group , multicentre phase III double-blind , placebo-controlled , with knee or hip osteoarthritis : a to diclofenac sustained release in patients Efficacy and safety of tanezumab added on

I. Davignon, E. Feist, Mark T. Brown, 2013 .